Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission …

CKH Wong, ICH Au, KTK Lau, EHY Lau… - The Lancet Infectious …, 2022 - thelancet.com
Background Data on the effectiveness of oral antivirals in patients with mild-to-moderate
COVID-19 are urgently needed. This retrospective cohort study aimed to evaluate the …

Molnupiravir Revisited—Critical Assessment of Studies in Animal Models of COVID-19

HB Rasmussen, PR Hansen - Viruses, 2023 - mdpi.com
Molnupiravir, a prodrug known for its broad antiviral activity, has demonstrated efficacy in
animal models of COVID-19, prompting clinical trials, in which initial results indicated a …

Real-world effectiveness of molnupiravir and nirmatrelvir/ritonavir among COVID-19 inpatients during Hong Kong's Omicron BA. 2 wave: an observational study

CKH Wong, ICH Au, KTK Lau, EHY Lau, BJ Cowling… - medRxiv, 2022 - medrxiv.org
Background Real-world evidence on the effectiveness of oral antivirals in mild-to-moderate
COVID-19 patients is urgently needed. This retrospective cohort study aims to evaluate the …

Interferon β-1a ring prophylaxis to reduce household transmission of SARS-CoV-2: a cluster randomised clinical trial

JA Castro-Rodriguez, EN Fish, ST Montgomery… - …, 2023 - thelancet.com
Background Accumulating evidence indicates that an early, robust type 1 interferon (IFN)
response to SARS-CoV-2 is important in determining COVID-19 outcomes, with an …

Monitoring antiviral active metabolite (N-hydroxycytidine) levels in plasma in presence of carboxylesterase-2 inhibitor verapamil using copper …

AZ Alanazi, K Alhazzani, AM Mostafa, J Barker… - Microchemical …, 2023 - Elsevier
This study focuses on the determination of the active metabolite of molnupiravir (MOL), N-
hydroxycytidine (NHC), using a square wave voltammetric (SWV) method. Carboxylesterase …

Virus-mediated cell fusion of SARS-CoV-2 variants

A Amidei, HM Dobrovolny - Mathematical Biosciences, 2024 - Elsevier
SARS-CoV-2 has the ability to form large multi-nucleated cells known as syncytia. Little is
known about how syncytia affect the dynamics of the infection or severity of the disease. In …

[HTML][HTML] Real-world effectiveness of early molnupiravir and nirmatrelvir/ritonavir among hospitalized, non-oxygen-dependent COVID-19 patients on admission during …

CK Wong, IC Au, KT Lau, EH Lau, BJ Cowling… - 2022 - europepmc.org
Background Effectiveness of oral antivirals in mild-to-moderate COVID-19 patients is
urgently needed. This retrospective cohort study aims to evaluate the clinical and virologic …

What Is New in Prophylaxis and Treatment of COVID-19 in Renal Transplant Patients? A Report from an ESOT Meeting on the Topic

M Salvadori - Transplantology, 2022 - mdpi.com
I should highlight that this manuscript is not a formal review on the topic, but a report from an
ESOT meeting held on 22 June 2022. The assumption of immunosuppressants exposes …

What is New in Prophylaxis and Treatment of Covid-19 in Renal Transplant Patients?

M Salvadori - 2022 - preprints.org
Kidney transplant recipients, because of a weak immune response due to the assumption of
immunosuppressant are exposed to the risk of COVID-19 infection. This fact realize the …